Home
Scholarly Works
Both oral and intravenous ibandronate effectively...
Conference

Both oral and intravenous ibandronate effectively prevent postmenopausal bone loss in women without osteoporosis.

Authors

Adachi JD; Christiansen C; Stakkestad JA; McClung M; Burdeska A; Mahoney P

Volume

18

Pagination

pp. S372-S372

Publisher

AMER SOC BONE & MINERAL RES

Publication Date

September 1, 2003

Name of conference

25th Annual Meeting of the American-Society-for-Bone-and-Mineral-Research

Conference place

MINNEAPOLIS, MINNESOTA

Conference start date

September 19, 2003

Conference end date

September 23, 2003

Conference proceedings

JOURNAL OF BONE AND MINERAL RESEARCH

ISSN

0884-0431

Contact the Experts team